Global Gastrointestinal Therapeutics and Diagnostics Technologies and Markets Report 2016-2021

Dublin, April 17, 2017 -- Research and Markets has announced the addition of the "Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets" report to their offering.

The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.

This report is designed to provide an in-depth look at the therapeutic and diagnostic options of various gastrointestinal disorders. The geographic scope of the report is global, with particular emphasis on the key markets such as the U.S. and the European Union Five (EU5). The estimated market data is also global in nature, with geographic segments such as the U.S., EU and Rest of the World (ROW). The report provides a brief overview of the gastrointestinal system, which provides an introduction to the disorders of the gastrointestinal system; cites risk factors, where applicable; presents current pharmaceutical treatments, market size and key market participants (both prescription and OTC); and presents potential treatments in R&D, potential market size and future market entrants.

This report provides:

- An overview of the global markets for gastrointestinal therapeutics and diagnostics.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
- Analyses of therapeutics currently on the market as well as potential products and classes of products that are likely to have a significant impact.
- Descriptions of the industry in detail, its relationship to the healthcare industry, its participants, and its trends for the future.
- Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities.
- Profiles of major players in the industry.

The market for gastrointestinal pharmaceuticals is divided into two general segments: prescription gastrointestinal pharmaceuticals and OTC gastrointestinal pharmaceuticals.

Similarly, the market for gastrointestinal diagnostics, testing and vaccines is divided into three general segments:

- Diagnostics and testing market.
- Medical devices (endoscopy)
- Vaccines.

The market is further broken down into the drugs to treat specific disorders within the gastrointestinal system, including the following:

- Gastrointestinal tract disorders.
- Gastrointestinal tract walls disorders.
- Gastrointestinal motility disorders.
- Gastrointestinal cancers.

Each sub-segment is covered in detail, describing the disorders and diseases, identifying currently available and potential products, and competitors.

Key Topics Covered:

1: Introduction Complimentary

- Study Goals And Objectives
- Reasons For Doing The Study
- Intended Audience
- Scope Of Report
- Methodology And Information Sources

2: Executive Summary

- Gastrointestinal Therapeutics And Diagnostics

3: Overview

- Gastric Cancer
- Inflammatory Bowel Disease (IBD)
- Constipation
- Opioid-Induced Constipation
- Gastroesophageal Reflux Disease

4: Etiology

- Anatomy And Physiology Of The Gastrointestinal System
- The Enteric Nervous System: An Overview
- Factors Affecting The Functioning Of The GI System
- Physiology Of The Gi System And The Role Of Each Part In The Gi Process

5: Prescription Therapy Market

- Antidiarrheals
- Antiemetics
- Gastrointestinal Cancer Treatments
- Gastroesophageal Reflux Disease Treatments
- Proton Pump Inhibitors
- Laxatives
- Bowel Anti-Inflammatory
- Other GI Drugs

6: OTC Therapy Market

- Antacids
- Locally Acting Antidiarrheals
- H2 Inhibitors
- Proton Pump Inhibitors
- Laxatives
- Total OTC Gastrointestinal Drug Market Size And Growth

7: Diagnostics And Devices Market

- Enteric Disease Testing Methods
- Global Market For Enteric Diagnostic Tests
- Campylobacter
- Norovirus
- Rotavirus
- Giardia Parasite
- E. Coli
- Cryptosporidium
- Shigella
- Typhoid
- Amebiasis
- Cholera
- Other (H. Pylori, Yersinia) Diagnostic Tests
- Medical Devices (Endoscopy)

8: Gastrointestinal Product Pipeline

- Therapies For Treating Gastric Cancer
- Gerd And Peptic Ulcers
- Therapies For Treating IBS
- Therapies For Treating Ulcerative Colitis And Crohn'S Disease

9: Patents

10: Company Profiles

- Allergan Plc
- Ardelyx Inc.
- Astellas Pharma Inc.
- Astrazeneca
- Celgene Corp.
- Clovis Oncology
- Daewoong Pharmaceutical Co., Ltd.
- ELI Lilly And Company
- Glaxosmithkline
- Horizon Pharma Plc
- Immunogenx
- Immunomedics
- Merck & Co.
- Merrimack Pharmaceuticals Inc.
- New Link Genetics
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Roche
- Sanofi
- Shire
- Sucampo Pharmaceuticals Inc.
- Synergy Pharmaceuticals Inc.
- Synthetic Biologics
- Taiho Pharmaceutical Co., Ltd.
- Takeda Pharmaceuticals
- Valeant Pharmaceuticals

For more information about this report visit http://www.researchandmarkets.com/research/wqkmrj/gastrointestinal

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Diagnostics, Gastrointestinal Drugs